Literature DB >> 31624007

Control of Viral Latency by Episome Maintenance Proteins.

Alessandra De Leo1, Abram Calderon1, Paul M Lieberman2.   

Abstract

The human DNA tumor viruses Epstein-Barr virus (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), and human papillomavirus (HPV) share the common property of persisting as multicopy episomes in the nuclei of rapidly dividing host cells. These episomes form the molecular basis for viral latency and are etiologically linked to virus-associated cancers. Episome maintenance requires epigenetic programming to ensure the proper control of viral gene expression, DNA replication, and genome copy number. For these viruses, episome maintenance requires a dedicated virus-encoded episome maintenance protein (EMP), namely LANA (KSHV), EBNA1 (EBV), and E2 (HPV). Here, we review common features of these viral EMPs and discuss recent advances in understanding how they contribute to the epigenetic control of viral episome maintenance during latency.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3D organization; E2; EBNA1; EBV; Gammaherpesvirus; HPV; KSHV; LANA; chromatin; epigenetics; episome; latency; maintenance; oligomerization; segregation

Mesh:

Substances:

Year:  2019        PMID: 31624007      PMCID: PMC6980450          DOI: 10.1016/j.tim.2019.09.002

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  141 in total

1.  Lytic but not latent replication of epstein-barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.

Authors:  P Bell; P M Lieberman; G G Maul
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.

Authors:  Mikio Yoshioka; Michelle M Crum; Jeffery T Sample
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

3.  Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence.

Authors:  Erika De León Vázquez; Vincent J Carey; Kenneth M Kaye
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

4.  The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.

Authors:  Thomas Günther; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2010-06-03       Impact factor: 6.823

5.  Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).

Authors:  Fang Lu; Priyankara Wikramasinghe; Julie Norseen; Kevin Tsai; Pu Wang; Louise Showe; Ramana V Davuluri; Paul M Lieberman
Journal:  Virol J       Date:  2010-10-07       Impact factor: 4.099

6.  Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells.

Authors:  Chen-Yu Wang; Bill Sugden
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-08       Impact factor: 11.205

7.  Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.

Authors:  Joseph H Jeong; Joshua Orvis; Jong Wook Kim; Curtis P McMurtrey; Rolf Renne; Dirk P Dittmer
Journal:  J Biol Chem       Date:  2004-01-24       Impact factor: 5.157

8.  Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.

Authors:  H Jacques Garrigues; Kellie Howard; Serge Barcy; Minako Ikoma; Ashlee V Moses; Gail H Deutsch; David Wu; Keiji Ueda; Timothy M Rose
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

9.  HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.

Authors:  Jayaraju Dheekollu; Andreas Wiedmer; Daniel Sentana-Lledo; Joel Cassel; Troy Messick; Paul M Lieberman
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

10.  Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination.

Authors:  Neneh Sallah; Anne L Palser; Simon J Watson; Nazzarena Labo; Gershim Asiki; Vickie Marshall; Robert Newton; Denise Whitby; Paul Kellam; Inês Barroso
Journal:  J Infect Dis       Date:  2018-10-20       Impact factor: 5.226

View more
  27 in total

Review 1.  Herpesvirus latency.

Authors:  Jeffrey I Cohen
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

2.  Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.

Authors:  John Pang; Nam Nguyen; Jens Luebeck; Vineet Bafna; Joseph Califano; Laurel Ball; Andrey Finegersh; Shuling Ren; Takuya Nakagawa; Mitchell Flagg; Sayed Sadat; Paul S Mischel; Guorong Xu; Kathleen Fisch; Theresa Guo; Gabrielle Cahill; Bharat Panuganti
Journal:  Clin Cancer Res       Date:  2021-09-21       Impact factor: 13.801

3.  The Epstein-Barr Virus Enhancer Interaction Landscapes in Virus-Associated Cancer Cell Lines.

Authors:  Weiyue Ding; Chong Wang; Yohei Narita; Hongbo Wang; Merrin Man Long Leong; Alvin Huang; Yifei Liao; Xuefeng Liu; Yusuke Okuno; Hiroshi Kimura; Benjamin Gewurz; Mingxian Teng; Shuilin Jin; Yoshitaka Sato; Bo Zhao
Journal:  J Virol       Date:  2022-09-12       Impact factor: 6.549

4.  Lytic Replication and Reactivation from B Cells Is Not Required for Establishing or Maintaining Gammaherpesvirus Latency In Vivo.

Authors:  Arundhati Gupta; Shana M Owens; Darby G Oldenburg; Douglas W White; J Craig Forrest
Journal:  J Virol       Date:  2022-06-01       Impact factor: 6.549

Review 5.  Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.

Authors:  Xueyi Zheng; Yuhua Huang; Kai Li; Rongzhen Luo; Muyan Cai; Jingping Yun
Journal:  Viruses       Date:  2022-05-10       Impact factor: 5.818

6.  Epstein-Barr Virus Episome Physically Interacts with Active Regions of the Host Genome in Lymphoblastoid Cells.

Authors:  Luopin Wang; Jun Laing; Bingyu Yan; Hufeng Zhou; Liangru Ke; Chong Wang; Yohei Narita; Zonghao Zhang; Matthew R Olson; Behdad Afzali; Bo Zhao; Majid Kazemian
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

7.  Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance.

Authors:  Jayaraju Dheekollu; Andreas Wiedmer; Kasirajan Ayyanathan; Julianna S Deakyne; Troy E Messick; Paul M Lieberman
Journal:  Cell       Date:  2021-01-21       Impact factor: 41.582

Review 8.  Utilization of Host Cell Chromosome Conformation by Viral Pathogens: Knowing When to Hold and When to Fold.

Authors:  Kinjal Majumder; Abigail J Morales
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

9.  EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein-Barr virus-associated gastric cancer.

Authors:  Samantha S Soldan; Emma M Anderson; Drew M Frase; Yue Zhang; Lisa B Caruso; Yin Wang; Julianna S Deakyne; Benjamin E Gewurz; Italo Tempera; Paul M Lieberman; Troy E Messick
Journal:  Gastric Cancer       Date:  2021-04-30       Impact factor: 7.701

Review 10.  Human Virus Transcriptional Regulators.

Authors:  Xing Liu; Ted Hong; Sreeja Parameswaran; Kevin Ernst; Ivan Marazzi; Matthew T Weirauch; Juan I Fuxman Bass
Journal:  Cell       Date:  2020-07-09       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.